MedPath

Vigabatrin

These highlights do not include all the information needed to use VIGABATRIN FOR ORAL SOLUTION safely and effectively. See full prescribing information for VIGABATRIN FOR ORAL SOLUTION. VIGABATRIN for oral solution Initial U.S. Approval: 2009

Approved
Approval ID

082d818a-4f4e-4675-98c6-91db0294e63c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 31, 2022

Manufacturers
FDA

Novadoz Pharmaceuticals LLC

DUNS: 081109687

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

vigabatrin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72205-093
Application NumberANDA215363
Product Classification
M
Marketing Category
C73584
G
Generic Name
vigabatrin
Product Specifications
Route of AdministrationORAL
Effective DateJuly 21, 2020
FDA Product Classification

INGREDIENTS (2)

VIGABATRINActive
Quantity: 50 mg in 1 mL
Code: GR120KRT6K
Classification: ACTIB
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vigabatrin - FDA Drug Approval Details